Zhitong Finance App News, Haoyuan Pharmaceutical (688131.SH) announced that the company's pre-listing employee shareholding platforms Shanghai Chenxiao Enterprise Management Consulting Center (limited partnership), Shanghai Chenmai Enterprise Management Center (limited partnership), and Shanghai Chenxi Pilot Management Consulting Partnership (limited partnership) plan to reduce the total holdings of the company's shares by no more than 4.99 million shares through centralized bidding within 3 months after 3 trading days from the date of disclosure of the shareholding reduction plan announcement.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.